AnalystBook Research · Company Intelligence

PMGC Holdings Inc.

ELABNasdaq

Built from PMGC Holdings Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

PMGC Holdings Inc.: Revenue was $590K; no prior-year comparison was inferred. Net loss widened to $7.748M from $6.246M. Free cash flow outflow widened to $6.376M from $5.496M. Net margin was -1313.00%. PMGC Holdings Inc.'s annual comparison also shows the earnings-quality screen is grey.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue was $590K; no prior-year comparison was inferredNote
  • ProfitabilityNet loss widened to $7.748M from $6.246MWatch
  • Cash flowFree cash flow outflow widened to $6.376M from $5.496MWatch
  • MarginsNet margin was -1313.00%Note
  • AccountingGoing-concern warningWatch
  • Insiders0 purchases and 0 salesNote

Business

Business Overview As of December 31, 2025, we manage and operate a diverse portfolio of four (4) wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors: ● Northstrive Biosciences Inc. ("Northstrive Biosciences") is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products.

Leadership changes

From PMGC Holdings Inc.'s own filings, the day they're filed.

  • Jordan R. Plews · Director · departureeff. 2024-12-23
  • Hatem Abou-Sayed · Chief Medical Officer · departureeff. 2024-08-01
  • George Kovalyov · director · appointment

Latest filings

  • 8-K · Company announcement2026-09-02
  • 8-K · Company announcement2026-08-27
  • 10-Q · Quarterly report2026-08-14
  • 8-K · Company announcement2026-07-09
  • 8-K · Company announcement2026-07-07
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about PMGC Holdings Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.